Solid lipid nanoparticles of lutein with improved dissolution behavior and oral absorption
The present study aimed to develop solid lipid nanoparticles of lutein (SLN/LT) with improved dissolution behavior and oral absorption. SLN/LT were prepared by a flash nanoprecipitation method using a multi-inlet vortex mixer, and their physicochemical, photochemical, and pharmacokinetic properties were evaluated. The mean particle size of SLN/LT re-dispersed in water was 237 nm, and small spherical particles with no significant aggregation were observed. LT significantly generated singlet oxygen upon exposure to pseudo-sunlight (250 W/m2, 1 h), suggesting its high photoreactivity. The remaining LT in LT solution, crystalline LT, and SLN/LT after irradiation with pseudo-sunlight (250 W/m2, 2 h) were 56.3, 86.7, and 101%, respectively. SLN/LT showed improved dissolution behavior of LT in simulated intestinal fluid, and the dissolved amounts of LT at 2 h were at least 50 times higher than that of crystalline LT. Orally administered SLN/LT (100 mg-LT/kg) exhibited enhanced oral absorption of LT, as evidenced by a relative bioavailability of 3.7 to crystalline LT in rats. SLN/LT may be a promising dosage form for orally available LT supplements, possibly leading to enhanced nutritional functions of LT.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Pharmaceutical development and technology - 28(2023), 9 vom: 12. Nov., Seite 877-883 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ueno, Kodai [VerfasserIn] |
---|
Links: |
---|
Themen: |
Dissolution |
---|
Anmerkungen: |
Date Completed 17.11.2023 Date Revised 17.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/10837450.2023.2270032 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363216847 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM363216847 | ||
003 | DE-627 | ||
005 | 20231226092855.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10837450.2023.2270032 |2 doi | |
028 | 5 | 2 | |a pubmed24n1210.xml |
035 | |a (DE-627)NLM363216847 | ||
035 | |a (NLM)37828716 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ueno, Kodai |e verfasserin |4 aut | |
245 | 1 | 0 | |a Solid lipid nanoparticles of lutein with improved dissolution behavior and oral absorption |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.11.2023 | ||
500 | |a Date Revised 17.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The present study aimed to develop solid lipid nanoparticles of lutein (SLN/LT) with improved dissolution behavior and oral absorption. SLN/LT were prepared by a flash nanoprecipitation method using a multi-inlet vortex mixer, and their physicochemical, photochemical, and pharmacokinetic properties were evaluated. The mean particle size of SLN/LT re-dispersed in water was 237 nm, and small spherical particles with no significant aggregation were observed. LT significantly generated singlet oxygen upon exposure to pseudo-sunlight (250 W/m2, 1 h), suggesting its high photoreactivity. The remaining LT in LT solution, crystalline LT, and SLN/LT after irradiation with pseudo-sunlight (250 W/m2, 2 h) were 56.3, 86.7, and 101%, respectively. SLN/LT showed improved dissolution behavior of LT in simulated intestinal fluid, and the dissolved amounts of LT at 2 h were at least 50 times higher than that of crystalline LT. Orally administered SLN/LT (100 mg-LT/kg) exhibited enhanced oral absorption of LT, as evidenced by a relative bioavailability of 3.7 to crystalline LT in rats. SLN/LT may be a promising dosage form for orally available LT supplements, possibly leading to enhanced nutritional functions of LT | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Dissolution | |
650 | 4 | |a lutein | |
650 | 4 | |a oral absorption | |
650 | 4 | |a photostability | |
650 | 4 | |a solid lipid nanoparticles | |
650 | 7 | |a Lipid Nanoparticles |2 NLM | |
650 | 7 | |a Lutein |2 NLM | |
650 | 7 | |a X72A60C9MT |2 NLM | |
650 | 7 | |a Lipids |2 NLM | |
700 | 1 | |a Matsushita, Tetsuya |e verfasserin |4 aut | |
700 | 1 | |a Sugihara, Monami |e verfasserin |4 aut | |
700 | 1 | |a Yamada, Kohei |e verfasserin |4 aut | |
700 | 1 | |a Sato, Hideyuki |e verfasserin |4 aut | |
700 | 1 | |a Onoue, Satomi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmaceutical development and technology |d 1998 |g 28(2023), 9 vom: 12. Nov., Seite 877-883 |w (DE-627)NLM094740194 |x 1097-9867 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2023 |g number:9 |g day:12 |g month:11 |g pages:877-883 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/10837450.2023.2270032 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2023 |e 9 |b 12 |c 11 |h 877-883 |